more about bitcoin Top Reviews

Market news: South Korean prosecutors summoned the Minister of Health to participate in the investigation.List of A-share share repurchase: 16 companies disclosed the progress of repurchase, and on December 12, a total of 16 companies issued announcements related to share repurchase. Among them, four companies disclosed the stock repurchase plan for the first time, two companies' repurchase plans were approved by the shareholders' meeting, four companies disclosed the implementation progress of stock repurchase, and six companies' repurchase plans have been implemented. Judging from the initial disclosure of the repurchase plan, the amount of a company's stock repurchase plan on that day exceeded 10 million. Nanshan aluminum, Longzhu Science and Technology and Longzhu Science and Technology have the highest repurchase plans, and they plan to repurchase no more than 600 million yuan, 5,895,100 yuan and 1,171,000 yuan respectively. Judging from the repurchase plan passed by the shareholders' meeting, the repurchase plans of two companies exceeded 10 million on that day. Huaan Securities and Tongkun have the highest repurchase amount, with the planned repurchase not exceeding 200 million yuan and 51,966,700 yuan respectively. Judging from the implementation progress of repurchase, Shunluo Electronics, Shengquan Group and Hailiang have the highest repurchase amounts, with 9.009 million yuan, 3.8251 million yuan and 3.5187 million yuan respectively. Judging from the completed repurchase, the repurchase amount of four companies on that day exceeded 10 million. Chengda Pharmaceutical Co., Ltd., Jinshi Resources Co., Ltd. and Yingfangwei Co., Ltd. have completed the highest repurchase amounts, with 57,061,600 yuan, 53,158,000 yuan and 31,405,600 yuan respectively.18 shares were rated by brokers, and Yuhetian's target increased by 54.72%. On December 11th, a total of 18 shares were rated by brokers, and 6 of them announced their target prices. According to the highest target price, Yuhetian, Steady Medical Care and Fulongma ranked in the top, with increases of 54.72%, 19.96% and 17.62% respectively. Judging from the direction of rating adjustment, the ratings of 12 stocks remain unchanged and 6 stocks are rated for the first time. In addition, one stock attracted the attention of many brokers, and Hagrid Communications was ranked in the top number, with two brokers rating it respectively. Judging from the Wind industry to which the rated stocks are bought, the number of rated stocks for technical hardware and equipment, capital goods and materials II is the largest, with 4, 3 and 2 respectively.

Japan's semiconductor sector rose collectively, with ADVANTEST up nearly 5%, DISCO up over 2% and Renesas Electronics up over 1%.Thirteen people were killed when Israeli forces attacked the southern and northern parts of the Gaza Strip. On the 12th, local time, the reporter of the General Station learned from the Palestinian side that Israeli forces bombed Rafah, a city in the southern part of the Gaza Strip, killing seven people and injuring many others. According to medical staff in Rafah, seven dead people were attacked while protecting a rescue truck that arrived in the city. In addition, the Israeli army bombed a residential building west of Gaza City in the northern Gaza Strip, killing six people. (CCTV)The tenth batch of national procurement officially opened, and the number of enterprises and varieties involved reached a record high. The tenth batch of centralized drug procurement organized by the state officially accepted the application materials of enterprises at 8: 00 this morning at No.398 Zhanyuan Road, Nanqiao New Town, Fengxian District, Shanghai. This centralized procurement involved 62 varieties and 263 product specifications, and the number of enterprises and varieties involved reached a record high. Among them, 33 enterprises competed for nine short-listed oral sustained-release formulations of sitagliptin. There are also a number of varieties that are billions in the market of public hospitals, such as doxorubicin hydrochloride liposome injection, cefoperazone injection, piperacillin injection, compound α -ketoacid oral sustained-release dosage form, norepinephrine injection and aspirin oral sustained-release dosage form. The sales scale in sample hospitals last year all exceeded 2 billion yuan. Hengrui Pharma, Kelun Pharmaceutical, Unacon and Zhengda Tianqing participated with many varieties. Note: According to the tenth batch of national adoption documents released before, the tenth batch of national adoption rules have changed a lot, such as canceling the protection mechanism of 50% price reduction and increasing the fuse recovery mechanism by 1.8 times, and the number of B-certified enterprises affects the number of final finalists.

The restricted shares with a market value of 2.546 billion yuan were lifted today. Yongda, Sitaili and Dameng Data were among the top companies in terms of market value. On Thursday (December 12), the restricted shares of 8 companies were lifted, with a total lifting amount of 175 million shares. According to the latest closing price, the total lifting market value was 2.546 billion yuan. Judging from the amount of lifting the ban, the number of shares lifted by the two companies exceeded 10 million. Si Taili, Yongda and Ningxin New Materials were among the top, with 95,895,400 shares, 65,203,300 shares and 6,633,200 shares respectively. Judging from the market value of lifting the ban, the number of shares lifted by the two companies exceeded 100 million yuan. Yongda Co., Ltd., Sitaili and Dameng Data are among the top companies in terms of market value, with market values of 1.039 billion yuan, 992 million yuan and 349 million yuan respectively. Judging from the proportion of shares released from the ban to the total share capital, the proportion of the two companies released from the ban exceeded 10%. Yongda Co., Ltd., Sitaili Co., Ltd. and Ningxincai Co., Ltd. have the highest proportion of lifting the ban, accounting for 27.17%, 21.87% and 7.13% respectively.Russia says it controls two settlements in Kursk, and the Ukrainian army says it will continue to hold its ground. On the 11th, local time, the Russian Defense Ministry reported that in the past day, Russian troops had taken control of Darinot and Plekhovo settlements in Kursk region. The circular also stated that the Ukrainian armed forces used six US-made Army tactical missiles on the same day to launch an attack on a military airport in Rostov, southern Russia. The falling of missile fragments caused personal injury, but no other serious losses were caused. Russia will respond to this attack. On the same day, the General Staff of the Ukrainian Armed Forces issued a battle report, saying that there were 140 battles in the frontline area that day, and the Ukrainian army continued to hold its ground and fully blocked the Russian army. Among them, the fighting in Pokrovsk and Kulahovo is the fiercest, and fighting continues in some areas. In addition, Sumeizhou and Chernigov continue to be attacked by Russian air. In the Kursk region, the Ukrainian army repelled 15 Russian attacks.Citic Jiantou: We are optimistic about the investment opportunities in the pharmaceutical industry in 2025, focusing on the opportunities of new increase and industry integration. Citic Jiantou Securities reported on December 11th that looking forward to 2025, the reform policy in the pharmaceutical field has been normalized, and the most noteworthy incremental policy in the medical insurance field is to establish a diversified payment system. The medical field is about to usher in the reform of "deep water areas" such as salary system and graded diagnosis and treatment, which is in line with expectations on the whole. At the same time, the innovation of China's pharmaceutical industry has gradually stepped onto the international stage, some sub-sectors will be marginally improved, and industry integration will begin. We are optimistic about the investment opportunities in the pharmaceutical industry in 2025. It is suggested to focus on the new increase (innovation, going out to sea, marginal change) and industry integration opportunities.